Jone Bjornestad1, Larry Davidson2, Inge Joa1,3, Tor Ketil Larsen1,4, Wenche Ten Velden Hegelstad1, Johannes Langeveld1, Marius Veseth5, Ingrid Melle6, Jan Olav Johannessen1,3, Kolbjorn Bronnick1,3. 1. a TIPS - Centre for Clinical Research in Psychosis, Stavanger University Hospital , Stavanger , Norway. 2. b Yale University, School of Medicine and Institution for Social and Policy Studies , New Haven , CT , USA. 3. c Network for Medical Sciences, University of Stavanger , Stavanger , Norway. 4. d Department of Clinical Medicine , Section of Psychiatry, University of Bergen , Bergen, Norway. 5. e Faculty of Health and Social Sciences , Bergen University College , Bergen , Norway , and. 6. f Norwegian Centre for Mental Disorders Research, University of Oslo , Oslo , Norway.
Abstract
BACKGROUND: There is lack of long-term controlled studies evaluating treatment effects of antipsychotic medication. A complete investigation should include the service user perspective. AIMS: To investigate experiences of clinically recovered service users of antipsychotic medications during and after a first episode of psychosis. METHOD: We used a thematic analytic approach within an interpretative-phenomenological framework. 20 clinically recovered service users were interviewed. RESULTS: Themes: (1) Antipsychotic drugs reduce mental chaos during the acute phase, (2) Non-stigmatizing environments were perceived to increase chances of successful use, (3) Antipsychotic drugs beyond the acute phase - considered to compromise the contribution of individual effort in recovery, (4) Prolonged use - perceived to reduce likelihood of functional recovery, (5) Antipsychotic medication was considered as a supplement to trustful relationships. CONCLUSIONS: Acute phase antipsychotic treatment was mostly perceived as advantageous by this sample, who was in clinical recovery. However, costs were often seen as outweighing benefits beyond the acute stage. Findings clearly emphasize the need for a collaborative approach to be integrated across all phases of care. This study underscores the need to investigate sub-group differences with regard to long-term antipsychotic treatment.
BACKGROUND: There is lack of long-term controlled studies evaluating treatment effects of antipsychotic medication. A complete investigation should include the service user perspective. AIMS: To investigate experiences of clinically recovered service users of antipsychotic medications during and after a first episode of psychosis. METHOD: We used a thematic analytic approach within an interpretative-phenomenological framework. 20 clinically recovered service users were interviewed. RESULTS: Themes: (1) Antipsychotic drugs reduce mental chaos during the acute phase, (2) Non-stigmatizing environments were perceived to increase chances of successful use, (3) Antipsychotic drugs beyond the acute phase - considered to compromise the contribution of individual effort in recovery, (4) Prolonged use - perceived to reduce likelihood of functional recovery, (5) Antipsychotic medication was considered as a supplement to trustful relationships. CONCLUSIONS: Acute phase antipsychotic treatment was mostly perceived as advantageous by this sample, who was in clinical recovery. However, costs were often seen as outweighing benefits beyond the acute stage. Findings clearly emphasize the need for a collaborative approach to be integrated across all phases of care. This study underscores the need to investigate sub-group differences with regard to long-term antipsychotic treatment.
Entities:
Keywords:
Recovery; antipsychotic; antipsychotic medication; clinical recovery; first episode psychosis; first-person accounts; psychosis; service user
Authors: Jone Bjornestad; Marius Veseth; Larry Davidson; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Ingrid Melle; Wenche Ten Velden Hegelstad Journal: Front Psychol Date: 2018-09-04